Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway Mehta D, Reister K, Sheridan J, Elkins J, Amaravadi L ACTRIMS-ECTRIMS 2014. 09/12/2014. CommentRecommendBookmarkWatch